Paul R. Kirchgraber
Executive Vice President and Chief Executive Officer, Early Development, Central Laboratories and OncologyatLabcorp Holdings· In proxies 2021–2023
Pay in FY2023+77% from the year before
Paul R. Kirchgraber was paid $5.3M in FY2023 (Dec), up 77%.
PayNo stock prices for these years
Experience
- Labcorp HoldingsPublic company · 5 yr
- Executive Vice President and Chief Executive Officer, Early Development, Central Laboratories and Oncology2021 – Present · 5 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?